Your browser doesn't support javascript.
loading
Immuno-monitoring reveals an extended subclinical disease activity in tocilizumab-treated giant cell arteritis.
Gloor, Andrea D; Yerly, Daniel; Adler, Sabine; Reichenbach, Stephan; Kuchen, Stefan; Seitz, Michael; Villiger, Peter M.
Afiliação
  • Gloor AD; Department of Rheumatology, Immunology and Allergology, University Hospital, Bern, Switzerland.
  • Yerly D; Department of Rheumatology, Immunology and Allergology, University Hospital, Bern, Switzerland.
  • Adler S; Department of Rheumatology, Immunology and Allergology, University Hospital, Bern, Switzerland.
  • Reichenbach S; Department of Rheumatology, Immunology and Allergology, University Hospital, Bern, Switzerland.
  • Kuchen S; Institute for Social and Preventive Medicine, University of Bern, Bern, Switzerland.
  • Seitz M; Department of Rheumatology, Immunology and Allergology, University Hospital, Bern, Switzerland.
  • Villiger PM; Department of Rheumatology, Immunology and Allergology, University Hospital, Bern, Switzerland.
Rheumatology (Oxford) ; 57(10): 1795-1801, 2018 10 01.
Article em En | MEDLINE | ID: mdl-29961816

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Arterite de Células Gigantes / Monitorização Imunológica / Anticorpos Monoclonais Humanizados / Quimioterapia de Indução / Glucocorticoides Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Arterite de Células Gigantes / Monitorização Imunológica / Anticorpos Monoclonais Humanizados / Quimioterapia de Indução / Glucocorticoides Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article